Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HER2-IN-11 is a psoralen derivative that induces apoptosis. HER2-IN-11 shows light-activated cytotoxicity and also exhibits anti-breast cancer activity [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | HER2-IN-11 is a psoralen derivative that induces apoptosis. HER2-IN-11 shows light-activated cytotoxicity and also exhibits anti-breast cancer activity [1]. |
In vitro | HER2-IN-11 (50 μM) has phototoxicity against SK-BR-3 cells with the IC 50 of 2.71 μM [1]. HER2-IN-11 (1-50 μM; 48 h) changes the morphology of the SK-BR-3 cells under UVA irradiation and increases the apoptotic index [1]. Apoptosis Analysis [1] Cell Line: SK-BR-3 cells Concentration: 1, 2.5, 5, 10, 20 and 50 μM Incubation Time: 48 hours Result: Broken down cells into apoptotic bodies at higher concentrations (10, 20, and 50 μM) and cell shrinkage, plasma membrane blebbing at lower concentrations (1, 2.5, and 5 μM). |
Molecular Weight | 325.27 |
Formula | C17H11NO6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.